1-11 of 11
Laurence Elias
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 396: Ibrutinib exerts potent antifibrotic activity in a mouse model of pancreatic adenocarcinoma

Daniel Massó-Vallés, Toni Jauset, Erika Serrano, Nicole M. Sodir, Kim Pedersen, Nesrine I. Affara, Jonathan R. Whitfield, Marie-Eve Beaulieu, Gerard I. Evan, Laurence Elias, Joaquín Arribas, Laura Soucek
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 396.
https://doi.org/10.1158/1538-7445.AM2015-396
Published: 01 August 2015
View article titled, Abstract 396: Ibrutinib exerts potent antifibrotic activity in a mouse model of pancreatic adenocarcinoma
Journal Articles

Ibrutinib Exerts Potent Antifibrotic and Antitumor Activities in Mouse Models of Pancreatic Adenocarcinoma

Daniel Massó-Vallés, Toni Jauset, Erika Serrano, Nicole M. Sodir, Kim Pedersen, Nesrine I. Affara, Jonathan R. Whitfield, Marie-Eve Beaulieu, Gerard I. Evan, Laurence Elias, Joaquín Arribas, Laura Soucek
Journal: Cancer Research
Series: Author Choice
Cancer Res (2015) 75 (8): 1675–1681.
https://doi.org/10.1158/0008-5472.CAN-14-2852
Published: 14 April 2015
View article titled, Ibrutinib Exerts Potent Antifibrotic and Antitumor Activities in Mouse Models of Pancreatic Adenocarcinoma
Open the PDF for Ibrutinib Exerts Potent Antifibrotic and Antitumor Activities in Mouse Models of Pancreatic Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 4564: Inhibitory effects of the BTK inhibitor, ibrutinib, on Her2 amplified breast cancer growth, cell cycle progression and clonogenicity

Jun Chen, Betty Y. Chang, Laurence Elias
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4564.
https://doi.org/10.1158/1538-7445.AM2014-4564
Published: 01 October 2014
View article titled, Abstract 4564: Inhibitory effects of the BTK inhibitor, ibrutinib, on Her2 amplified breast cancer growth, cell cycle progression and clonogenicity
Journal Articles

Abstract 3519: Mobilization of follicular lymphoma cells into peripheral blood following BTK inhibition by ibrutinib.

Betty Y. Chang, Padmaja Magadala, Michelle Francesco, Sriram Balasubramanian, Laurence Elias, Joseph J. Buggy
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3519.
https://doi.org/10.1158/1538-7445.AM2013-3519
Published: 15 April 2013
View article titled, Abstract 3519: Mobilization of follicular lymphoma cells into peripheral blood following BTK inhibition by ibrutinib.
Journal Articles

Abstract 2934: Targeting Bruton's tyrosine kinase with PCI-32765 blocks growth and survival of multiple myeloma and Waldenström macroglobulinemia via potent inhibition of osteoclastogenesis, cytokines/chemokine secretion, and myeloma stem-like cells in the bone marrow microenvironment

Yu-Tzu Tai, Betty Chang, Sun-Young Kong, Mariateresa Fulciniti, Guang Yang, Yolanda Calle, Yiguo Hu, Jianhong Lin, Jian-Jun Zhao, Antonia Cagnetta, Michele Cea, Michael Sellitto, Michelle Chen, Daniel R. Carrasco, Laurence Elias, Joseph Buggy, Steven P. Treon, Zachary Hunter, William Matsui, Paul Richardson, Nikhil C. Munshi, Kenneth C. Anderson
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2934.
https://doi.org/10.1158/1538-7445.AM2012-2934
Published: 15 April 2012
View article titled, Abstract 2934: Targeting Bruton's tyrosine kinase with PCI-32765 blocks growth and survival of multiple myeloma and Waldenström macroglobulinemia via potent inhibition of osteoclastogenesis, cytokines/chemokine secretion, and myeloma stem-like cells in the bone marrow microenvironment
Journal Articles

Combination therapy of recombinant interleukin-2 and targeted small molecule receptor tyrosine kinase inhibitors (BAY 43-9006 or SU11248) augment anticancer activity in preclinical tumor models

Daniel Lopes de Menezes, Kimberly Denis-Mize, James Chou, Yan Tang, Helen Ye, John Kunich, Katherine Porth, Laurence Elias, Bahija Jallal, Sharon Aukerman
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 972.
Published: 01 May 2007
View article titled, Combination therapy of recombinant interleukin-2 and targeted small molecule receptor tyrosine kinase inhibitors (BAY 43-9006 or SU11248) augment anticancer activity in preclinical tumor models
Journal Articles

Proleukin (aldesleukin, rhIL-2) immunotherapy in combination with rituximab following initial CHOP/rituximab treatment induces highly durable complete responses in a xenograft model of indolent B-cell Non-Hodgkin’s lymphoma

Daniel E. Lopes de Menezes, Kimberly Denis-Mize, Carla Heise, Arnold B. Gelb, Helen Ye, Yan Tang, John Kunich, Sandra Milan, Laurence Elias, Susan E. Wilson, Lea Aukerman, Bahija Jallal
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 131.
Published: 01 May 2005
View article titled, Proleukin (aldesleukin, rhIL-2) immunotherapy in combination with rituximab following initial CHOP/rituximab treatment induces highly durable complete responses in a xenograft model of indolent B-cell Non-Hodgkin’s lymphoma
Journal Articles

Interferon Effects upon the Adenocarcinoma 38 and HL-60 Cell Lines: Antiproliferative Responses and Synergistic Interactions with Halogenated Pyrimidine Antimetabolites

Laurence Elias, Harry A. Crissman
Journal: Cancer Research
Cancer Res (1988) 48 (17): 4868–4873.
Published: 01 September 1988
View article titled, Interferon Effects upon the Adenocarcinoma 38 and HL-60 Cell Lines: Antiproliferative Responses and Synergistic Interactions with Halogenated Pyrimidine Antimetabolites
Open the PDF for Interferon Effects upon the Adenocarcinoma 38 and HL-60 Cell Lines: Antiproliferative Responses and Synergistic Interactions with Halogenated Pyrimidine Antimetabolites in another window
Journal Articles

Effects of Conditioned Medium upon Proliferation, Deoxynucleotide Metabolism, and Antimetabolite Sensitivity of Promyelocytic Leukemic Cells in Vitro

Laurence Elias, Allan Wood, Harry A. Crissman, Robert Ratliff
Journal: Cancer Research
Cancer Res (1985) 45 (12_Part_1): 6301–6307.
Published: 01 December 1985
View article titled, Effects of Conditioned Medium upon Proliferation, Deoxynucleotide Metabolism, and Antimetabolite Sensitivity of Promyelocytic Leukemic Cells <em>in Vitro</em>
Open the PDF for Effects of Conditioned Medium upon Proliferation, Deoxynucleotide Metabolism, and Antimetabolite Sensitivity of Promyelocytic Leukemic Cells <em>in Vitro</em> in another window
Journal Articles

Subcellular Distribution of Cyclic Adenosine 3′:5′-Monophosphatedependent Protein Kinase during the Chemically Induced Differentiation of HL-60 Cells

Laurence Elias, Thomas Stewart
Journal: Cancer Research
Cancer Res (1984) 44 (7): 3075–3080.
Published: 01 July 1984
View article titled, Subcellular Distribution of Cyclic Adenosine 3′:5′-Monophosphatedependent Protein Kinase during the Chemically Induced Differentiation of HL-60 Cells
Open the PDF for Subcellular Distribution of Cyclic Adenosine 3′:5′-Monophosphatedependent Protein Kinase during the Chemically Induced Differentiation of HL-60 Cells in another window
Journal Articles

Cyclic Adenosine 3′:5′-Monophosphate-dependent and -independent Protein Kinase in Acute Myeloblastic Leukemia

Laurence Elias, Albert P. Li, Jonathan Longmire
Journal: Cancer Research
Cancer Res (1981) 41 (6): 2182–2188.
Published: 01 June 1981
View article titled, Cyclic Adenosine 3′:5′-Monophosphate-dependent and -independent Protein Kinase in Acute Myeloblastic Leukemia
Open the PDF for Cyclic Adenosine 3′:5′-Monophosphate-dependent and -independent Protein Kinase in Acute Myeloblastic Leukemia in another window